154 related articles for article (PubMed ID: 10773931)
1. Defective growth hormone (GH) secretion and short-term treatment in Noonan syndrome.
Soliman AT; Rajab A; el Zalabany M; alSalmi I; Fattah MA
Indian J Pediatr; 1998; 65(5):741-9. PubMed ID: 10773931
[TBL] [Abstract][Full Text] [Related]
2. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia.
Soliman AT; El Banna N; Ansari BM
Eur J Endocrinol; 1998 Apr; 138(4):394-400. PubMed ID: 9578506
[TBL] [Abstract][Full Text] [Related]
3. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
[TBL] [Abstract][Full Text] [Related]
4. GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome.
Dahlgren J; Albertsson-Wikland K
Front Endocrinol (Lausanne); 2021; 12():737893. PubMed ID: 34858328
[TBL] [Abstract][Full Text] [Related]
5. Empty sella in short children with and without hypothalamic-pituitary abnormalities.
Soliman AT; Darwish A; Asfour MG
Indian J Pediatr; 1995; 62(5):597-603. PubMed ID: 10829929
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.
Fuchs S; Gat-Yablonski G; Shtaif B; Lazar L; Phillip M; Lebenthal Y
J Endocrinol Invest; 2015 Apr; 38(4):399-406. PubMed ID: 25344824
[TBL] [Abstract][Full Text] [Related]
8. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth.
Soliman AT; elZalabany MM; Mazloum Y; Bedair SM; Ragab MS; Rogol AD; Ansari BM
J Trop Pediatr; 1999 Dec; 45(6):327-37. PubMed ID: 10667001
[TBL] [Abstract][Full Text] [Related]
10. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
11. Reliability of clonidine testing for the diagnosis of growth hormone deficiency in children and adolescents.
Ibba A; Guzzetti C; Casula L; Salerno M; Di Iorgi N; Allegri AME; Cappa M; Maghnie M; Loche S
Clin Endocrinol (Oxf); 2018 Dec; 89(6):765-770. PubMed ID: 30171702
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
[TBL] [Abstract][Full Text] [Related]
13. Age related IGF-I changes and IGF-I generation in thalassemia major.
Soliman AT; Abushahin A; Abohezeima K; Khalafallah H; Adel A; Elawwa A; Elmulla N
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():278-83. PubMed ID: 21705978
[TBL] [Abstract][Full Text] [Related]
14. Isolated growth hormone deficiency in children with vertically transmitted short stature: What do the genes tell us?
Plachy L; Amaratunga SA; Dusatkova P; Maratova K; Neuman V; Petruzelkova L; Zemkova D; Obermannova B; Snajderova M; Kolouskova S; Sumnik Z; Lebl J; Pruhova S
Front Endocrinol (Lausanne); 2022; 13():1102968. PubMed ID: 36714562
[TBL] [Abstract][Full Text] [Related]
15. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
16. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
17. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
Bertelloni S; Baroncelli GI; Dati E; Ghione S; Baldinotti F; Toschi B; Simi P
Hormones (Athens); 2013; 12(1):86-92. PubMed ID: 23624134
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
19. Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.
Battelino T; Rasmussen MH; De Schepper J; Zuckerman-Levin N; Gucev Z; Sävendahl L;
Clin Endocrinol (Oxf); 2017 Oct; 87(4):350-358. PubMed ID: 28656605
[TBL] [Abstract][Full Text] [Related]
20. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
Chaler EA; Rivarola MA; Guerci B; Ciaccio M; Costanzo M; Travaglino P; Maceiras M; Pagani S; Meazza C; Bozzola E; Barberi S; Bozzola M; Belgorosky A
Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
